Synthesis, characterization and biocompatibility of cadmium sulfide nanoparticles capped with dextrin for in vivo and in vitro imaging application

Journal of Nanobiotechnology

Volumn 13, Issue 1, 2015, Pages

  Reyes Esparza, Jorge ^a   Martínez Mena, Alberto ^a   Gutiérrez Sancha, Ivonne ^a   Rodríguez Fragoso, Patricia ^b   Cruz, Gerardo Gonzalez ^b   Mondragon R ^b   Rodríguez Fragoso, Lourdes ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MORELOS   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Apoptosis; Biocompatibility biodistribution; Cadmium sulfide nanoparticles; Cytotoxicity; Quantum dot

Indexed keywords

ANIMALS; BIOCOMPATIBILITY; BIOLOGICAL ORGANS; CADMIUM; CELL DEATH; CYTOLOGY; CYTOTOXICITY; FLUORESCENCE; HISTOLOGY; IMAGE SEGMENTATION; MAMMALS; NANOCRYSTALS; NANOPARTICLES; SEMICONDUCTOR QUANTUM DOTS; SULFUR COMPOUNDS; SYNTHESIS (CHEMICAL); TISSUE; TOXICITY;

ADVERSE HEALTH EFFECTS; BIODISTRIBUTIONS; BIOLOGICAL CHARACTERISTIC; CADMIUM SULFIDE NANOPARTICLE; DISTRIBUTION PATTERNS; PHYSICOCHEMICAL PROPERTY; SEMICONDUCTOR NANOPARTICLES; SUBCELLULAR LOCALIZATIONS;

CADMIUM SULFIDE;

CADMIUM SULFIDE NANOPARTICLE; DEXTRIN; NANOPARTICLE; UNCLASSIFIED DRUG; BIOMATERIAL; CADMIUM DERIVATIVE; CADMIUM SULFIDE; QUANTUM DOT; SULFIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; BRAIN TISSUE; CELL DEATH; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; EMBRYO; FEMALE; FLUORESCENCE MICROSCOPY; HEK293 CELL LINE; HELA CELL LINE; HEPG2 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PARENCHYMA; LIVER PARENCHYMA; LUNG PARENCHYMA; MALE; MATERIAL COATING; MOLECULAR IMAGING; NONHUMAN; RAT; SPLENIC TISSUE; TESTIS; TISSUE DISTRIBUTION; CELL SURVIVAL; CHEMISTRY; DIAGNOSTIC IMAGING; ENDOCYTOSIS; HEP-G2 CELL LINE; PROCEDURES; SYNTHESIS; ULTRASTRUCTURE;

BIOCOMPATIBLE MATERIALS; CADMIUM COMPOUNDS; CELL DEATH; CELL SURVIVAL; DEXTRINS; DIAGNOSTIC IMAGING; ENDOCYTOSIS; HEK293 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; QUANTUM DOTS; SULFIDES; TISSUE DISTRIBUTION;

EID: 84946950159     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/s12951-015-0145-x     Document Type: Article

References (46)

1. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J. 2005;19:311-30.
2. Rosenblum LT, Kosaka N, Mitsunaga M, Choyke PL, Kobayashi H. In vivo molecular imaging using nanomaterials: general in vivo characteristics of nano-sized reagents and applications for cancer diagnosis. Mol Membr Biol. 2010;27:274-85.
3. Madani SY, Shabani F, Dwek MV, Seifalian AM. Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment. Int J Nanomedicine. 2013;8:941-50.
4. Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63:185-98.
5. Li JJ, Wang YA, Guo W, Keay JC, Mishima TD, Johnson MB, Peng X. Large-scale synthesis of nearly monodisperse CdSe/CdS core/shell nanocrystals using air-stable reagents via successive ion layer adsorption and reaction. J Am Chem Soc. 2003;125:12567-75.
6. Williams DF. On the mechanisms of biocompatibility. Biomaterials. 2008;29:2941-53.
7. Nan C, Yao H, Yuanyuan S, Xiaoming L, Qing H, Haifeng W, Xiangzhi Z, Renzhong T, Chunhai F. The cytotoxicity of cadmium-based quantum dots. Biomaterials. 2012;33:1238-44.
8. Li KG, Chen JT, Bai SS, Wen X, Song SY, Yu Q, Wang YQ. Intracellular oxidative stress and cadmium ions release induce cytotoxicity of unmodified cadmium sulfide quantum dots. Toxicol In Vitro. 2009;23:1007-13.
9. Godt J, Scheidig F, Grosse-Siestrup C, Esche V, Brandenburg P, Reich A, Groneberg DA. The toxicity of cadmium and resulting hazards for human health. J Occup Med Toxicol. 2006;10:1-22.
10. Ipe BI, Lehnig M, Niemeyer CM. On the generation of free radical species from quantum dots. Small. 2005;1:706-9.
11. Choi AO, Brown SE, Szyf M, Maysinger D. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J Mol Med. 2008;86:291-302.
12. Zhang Y, Clapp A. Overview of stabilizing ligands for biocompatible quantum dot nanocrystals. Sensor. 2011;11:11036-55.
13. Zhou L, Gao C, Xu W, Wang X, Xu Y. Enhanced biocompatibility and biostability of CdTe quantum dots by facile surface-initiated dendritic polymerization. Biomacromolecules. 2009;10(7):1865-74.
14. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2:347-60.
15. Shen L. Biocompatible polymer/quantum dots hybrid materials: current status and future developments. J Funct Biomater. 2011;2:355-72.
16. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nano-particles in rats. Mol Pharmacol. 2008;5:316-27.
17. Rosenthal SJ, Chang JC, Kovtun O, McBride JR, Tomlinson ID. Biocompatible quantum dots for biological applications. Chem Biol. 2011;18:10-24.
18. Rodriguez P, Muñoz-Aguirre N, San-Martin ME, Gonzalez de la Cruz G, Tomas SA, Zelaya AO. Synthesis and spectral properties of starch capped CdS nanoparticles in aqueous solution. J Cryst Growth. 2008;310:160-4.
19. Rodríguez-Fragoso P, Reyes-Esparza J, León-Buitimea A, Rodríguez-Fragoso L. Synthesis, characterization and toxicological evaluation of maltodextrin capped cadmium sulfide nanoparticles in human cell lines and chicken embryos. J Nanobiotechnology. 2012;10:47.
20. Brus LE. Electron-electron and electron-hole interactions in small semiconductor crystallites: the size dependence of the lowest excited electronic state. J Chem Phys. 1984;80:4403-39.
21. Kairdolf BA, Smith AM, Stokes TH, Wang MD, Young AN, Nie S. Semiconductor quantum dots for bioimaging and biodiagnostic applications. Annu Rev Anal Chem. 2013;6:143-62.
22. Li X, Wang L, Fan Y, Feng Q, Cui FZ. Biocompatibility and toxicity of nanoparticles and nanotubes. J Nanomater. 2012;6:19.
23. Nel A, Xia T, Mädler L, Li N. Toxic potential of materials at the nanolevel. Science. 2006;311:622-7.
24. Kirchner C, Liedl T, Kudera S, Pellegrino T, Muñoz JA, Gaub HE, Stolzle S, Fertig N, Parak WJ. Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 2005;5:331-8.
25. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology. 2000;7:153-63.
26. Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect. 2006;114:165-72.
27. Winnik FM, Maysinger D. Quantum dot cytotoxicity and ways to reduce it. Acc Chem Res. 2013;46:672-80.
28. Rzigalinski BA, Strobl JS. Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol. 2009;238:280-8.
29. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small. 2010;6:12-21.
30. Barua S, Rege K. Cancer-cell-phenotype-dependent differential intracellular trafficking of unconjugated quantum dots. Small. 2009;5:370-6.
31. Damalakiene L, Karabanovas V, Bagdonas S, Valius M, Rotomskis R. Intracellular distribution of nontargeted quantum dots after natural uptake and microinjection. Int J Nanomedicine. 2013;8:555-68.
32. Shang W, Zhang X, Zhang M, Fan Z, Sun Y, Han M, Fan L. The uptake mechanism andbiocompatibilityof graphenequantum dotswith human neural stem cells. Nanoscale. 2014;6:5799-806.
33. Lederer M, Leipzig-Paganini E. Dextrin as excipient in pharmaceutical preparations. Pharmazie. 2000;55:378-9.
34. Yoo JW, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des. 2010;16:2298-307.
35. Yang RS, Chang LW, Wu JP, Tsai MH, Wang HJ, Kuo YC, Yeh TK, Yang CS, Lin P. Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect. 2007;115:1339-43.
36. Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9:223-43.
37. Cupaioli FA, Zucca FA, Boraschi D, Zecca L. Engineered nanoparticles. How brain friendly is this new guest? Prog Neurobiol. 2014;119:20-38.
38. Hervé F, Ghinea N, Scherrmann JM. CNS delivery via adsorptive transcytosis. AAPS J. 2008;10:455-72.
39. Fischer HC, Liu L, Pang KS, Chan WC. Pharmacokinetics of nanoscale quantum dots: in vivo distribution, sequestration, and clearance in the rat. Adv Funct Mater. 2006;16:1299-305.
40. Chen Z, Chen H, Meng H, Xing G, Gao X, Sun B, Fang X. Bio-distribution and metabolic paths of silica coated CdSeS quantum dots. Toxicol Appl Pharmacol. 2008;230:364-71.
41. Monici M. Cell and tissue autofluorescence research and diagnostic applications. Biotechnol Annu Rev. 2005;11:227-56.
42. Viegas MS, Martins TC, Seco F, Carmo A. An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissues. Eur J Histochem. 2006;52:59-66.
43. Wang HZ, Chang CH, Lin CP, Tsai MC. Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells. J Ocul Pharmacol Ther. 1996;12:35-43.
44. Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D, Ojcius DM, Jäättelä M, Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med. 2003;197:1323-34.
45. Muñiz-Hernández S, González del Carmen M, Mondragón M, Mercier C, Cesbron MF, Mondragón-González SL, González S, Mondragón R. Contribution of the residual body in the spatial organization of toxoplasma gondii tachyzoites within the parasitophorous vacuole. J Biomed Biotech. 2011; ID 473983, 11 pages. doi: 10.1155/2011/473983.
46. Bayne K. Revised guide for the care and use of laboratory animals available. Am Physiol Soc Physiol. 1996;39:208-11.